The Early Anomaly Scan is performed between 11–14 weeks of pregnancy to assess your baby’s initial development and detect major structural abnormalities at an early stage.

Clarity and reassurance when you need it most A Second Opinion Scan is recommended when there is: A doubtful or abnormal finding in a previous scan

Advanced imaging for uterine and tubal assessment Saline Infusion Sonography (SIS) and HyCoSy are specialized ultrasound procedures used to evaluate:

Early detection for a healthier future Thalassemia screening is a simple blood test to identify whether parents are carriers of thalassemia, a genetic blood disorder.

Comprehensive evaluation of your baby’s development Also known as the Level II scan, this detailed ultrasound is usually performed between 18 to 22 weeks.

Guidance, support, and informed decision-making Genetic Counseling helps parents understand: Risk of genetic or chromosomal conditions

A definitive diagnostic test for genetic conditions Amniocentesis is usually performed after 15 weeks of pregnancy. A small amount of amniotic fluid is collected under ultrasound guidance for laboratory analysis.

Early diagnosis, earlier reassurance CVS is performed between 11 to 13 weeks of pregnancy. A small sample of placental tissue is collected for genetic testing.

Life-saving treatment before birth Intrauterine Transfusion is a specialized procedure used to treat severe fetal anemia while the baby is still in the womb.

A highly advanced and safe screening test, NIPT analyzes fetal DNA circulating in the mother’s blood to assess the risk of chromosomal abnormalities. Performed as early as 10 weeks of pregnancy, it offers high accuracy in detecting conditions such as Down syndrome, trisomy 18, and trisomy 13. This non-invasive test requires only a simple blood sample, ensuring complete safety for both mother and baby. It is especially recommended in high-risk pregnancies or advanced maternal age. NIPT helps in early risk assessment and guides further diagnostic decisions when required.

The Double Marker Test is an important first-trimester screening conducted between 11 and 14 weeks of pregnancy. It evaluates specific biochemical markers in the mother’s blood to estimate the risk of chromosomal abnormalities. Often combined with NT scan findings, it improves the accuracy of early screening. This test helps in identifying the likelihood of conditions like Down syndrome and trisomy 18. It is completely safe and non-invasive, providing valuable early insights into fetal health. Based on the results, further evaluation or reassurance can be planned.

The Quadruple Marker Test is a second-trimester screening test performed between 15 and 20 weeks of pregnancy. It measures four key biochemical markers in the mother’s blood to assess the risk of chromosomal abnormalities and neural tube defects. This test is particularly useful for those who have missed first-trimester screening. It provides a comprehensive risk assessment for conditions like Down syndrome. The results are interpreted along with maternal age and clinical history for better accuracy. It supports timely decision-making and further diagnostic planning if needed.

Fetal echocardiography is a specialized ultrasound designed to assess the structure and function of the baby’s heart in detail. Typically performed between 18 and 24 weeks, it helps in the early detection of congenital heart defects. This scan is recommended in cases of high-risk pregnancy, abnormal routine scans, or family history of cardiac conditions. It is completely safe and non-invasive, providing detailed imaging of fetal cardiac activity. Early diagnosis enables better planning and management of care before and after birth. TTTS Management (Twin-to-Twin Transfusion Syndrome)

Twin-to-Twin Transfusion Syndrome (TTTS) is a serious condition seen in identical twins sharing a placenta, where there is an imbalance in blood flow between the twins. Early diagnosis through detailed ultrasound monitoring is crucial for timely intervention. Management depends on the severity and may include close surveillance or advanced procedures such as fetoscopic laser therapy. With expert care and timely treatment, outcomes can be significantly improved. Comprehensive monitoring and specialized fetal medicine support are essential in managing such high-risk twin pregnancies.